John Peter Mclaughlin - May 25, 2022 Form 4 Insider Report for LENSAR, Inc. (LNSR)

Role
Director
Signature
/s/ Thomas R. Staab, II, attorney-in-fact
Stock symbol
LNSR
Transactions as of
May 25, 2022
Transactions value $
$0
Form type
4
Date filed
5/27/2022, 09:27 PM
Previous filing
Jun 22, 2021
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LNSR Common Stock Award $0 +4.29K +10.7% $0.00 44.3K May 25, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LNSR Stock Option (Right to Buy) Award $0 +15.6K $0.00 15.6K May 25, 2022 Common Stock 15.6K $7.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer
F2 Includes 40,058 shares of the Issuer's common stock received by the Reporting Person in connection with the October 1, 2020 spin-off (the "Spin-Off Date") of the Issuer from PDL BioPharma, Inc. ("PDL") on account of his ownership of shares of PDL common stock.
F3 The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.